Invesco’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Invesco's GOSS Position: Q2 2026 in Review
Invesco reduced its Gossamer Bio (GOSS) stake by 4.9% in Q2 2026, selling an estimated $6.34K and leaving 442,268 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.
Invesco first reported a position in GOSS in Q4 2020 and has held it in 16 quarters since. The position peaked at $11.7M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Invesco held 442,268 shares of Gossamer Bio worth $72.8K as of Q2 2026.
- Invesco sold 22,700 Gossamer Bio shares in Q2 2026, an estimated $6.34K.
- Gossamer Bio made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3769 holding.
- Invesco first reported a position in Gossamer Bio in Q4 2020 and has held it in 16 quarters since.
- Invesco's Gossamer Bio position peaked at $11.7M in Q3 2022.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.